HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Generation of specific monoclonal antibodies against the extracellular loops of human claudin-3 by immunizing mice with target-expressing cells.

Abstract
Human claudin-3 (CLDN3) is a tetraspanin transmembrane protein of tight junction structures and is known to be over-expressed in some malignant tumors. Although a specific monoclonal antibody (MAb) against the extracellular domains of CLDN3 would be a valuable tool, generation of such MAbs has been regarded as difficult using traditional hybridoma techniques, because of the conserved sequence homology of CLDN3s among various species. In addition, high sequence similarity is shared among claudin family members, and potential cross-reactivity of MAb should be evaluated carefully. To overcome these difficulties, we generated CLDN3-expressing Chinese hamster ovary and Sf9 cells to use an immunogens and performed cell-based screening to eliminate cross-reactive antibodies. As a result, we generated MAbs that recognized the extracellular loops of CLDN3 but not those of CLDN4, 5, 6, or 9. Further in vitro studies suggested that the isolated MAbs possessed the desired binding properties for the detection or targeting of CLDN3.
AuthorsHiroshi Ando, Masayo Suzuki, Mariko Kato-Nakano, Shinobu Kawamoto, Hirofumi Misaka, Naoya Kimoto, Akiko Furuya, Kazuyasu Nakamura
JournalBioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem) Vol. 79 Issue 8 Pg. 1272-9 ( 2015) ISSN: 1347-6947 [Electronic] England
PMID25744656 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Claudin-3
Topics
  • Animals
  • Antibodies, Monoclonal (chemistry, immunology)
  • Antibody Specificity (immunology)
  • CHO Cells
  • Claudin-3 (chemistry, immunology)
  • Cricetinae
  • Cricetulus
  • Humans
  • Mice
  • Protein Structure, Tertiary

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: